Categorynews

Global Bird Flu Treatment Market Research Report to 2027 – Players Include Aurobindo Pharma, BioCryst Pharmaceuticals, Bristol-Myers Squibb and Chewy – ResearchAndMarkets.com

July 6, 2022 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Bird Flu Treatment Market Research Report by Type (Antivirals, Combination Treatment, and Prophylactic Antibiotics), End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Bird Flu Treatment Market size was estimated at USD 18.93 billion in 2021, USD 20.42 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.07% to reach USD 30.17 billion by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bird Flu Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bird Flu Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bird Flu Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bird Flu Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Bird Flu Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Bird Flu Treatment Market?

6. What is the market share of the leading vendors in the Global Bird Flu Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Bird Flu Treatment Market?

Market Dynamics

Drivers

  • Increasing prevalence of avian influenza and other zoonotic diseases
  • Rising government awareness of bird flu and measures to prevent the spread of bird flu
  • Rising government spending on development of better solutions

Restraints

  • Resistance of the virus to existing antiviral drugs

Opportunities

  • Emerging investment by major players for product development for bird flu
  • Ongoing clinical trial for bird flu treatment

Challenges

  • Inadequate manufacturing technology to support vaccine production

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Alltech, Inc.
  • Aurobindo Pharma Limited
  • BioCryst Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Chewy, Inc
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Forest Pharmaceuticals, Inc.
  • Gilead Sciences Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sinovac Biotech Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/v5d45k

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900